Media & Press Updates

​​​

• New -April 21, 2021 - National Cancer Institute (NCI) technologies added to OniX

• September 9, 2020 - Asahi Kasei Pharma Corporation Joins OniX: Partnerships to accelerate research in Pain Management, Neurodegenerative Diseases, Autoimmune Diseases, Critical Care and Refractory Muscle Diseases

​​

• Coming soon - TBA - Partnering, In/Out Licensing and Funding opportunities in:​

  • Osteoarthritis

  • Neurosciences: Alzheimer's, Mild Cognitive Impairment, Parkinson's, Depressive Disorders, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Multiple System Atrophy (MSA), Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Huntington's and others

  • Orthopedic/Musculoskeletal Diseases, Metabolic Diseases and CNS Diseases

  • Skin Diseases

  • Oncology: Lung, Pancreas, Breast, Skin, Prostate, Blood, and others

  • Gastrointestinal, Liver and Pancreatic Diseases

  • Rare Neurological Disorders

  • Lysosomal Storage Disorders

  • Others: Agriculture, Animal Health, Energy, Food & Nutrition and others

​​

• September 1, 2020: OniX and Skipper Bio Med Partner to advance Lung and Pancreatic Cancer research

• October 29, 2019: THE OniX - ALTUM Competitive Advantage: Transform the grants, prizes and challenges experience

• October 22, 2019: OniX partners with Altum to accelerate research:Grants|Prizes|Challenges Initiative

• October 14, 2019: OniX: New Startup Changing The Game